GET DAILY SIGNALSHorizon Technology Finance (HRZN): Is a +23% Move to the $5.00 Analyst Target Plausible?
Key Takeaways
- The $5.00 central target represents the average of six current analyst price targets ranging from $4.50 to $6.00.
- At roughly $4.07, HRZN would require an advance of about 23% to reach that level, a notable move for a dividend-focused BDC.
- Analyst ratings lean cautious, with two Buy ratings and the balance at Hold, Market Perform, or Neutral.
- Positive elements include a high portfolio yield, trading below net asset value, and monthly distributions yielding near 18%.
- Primary risks center on distribution coverage, potential credit write-downs, and pressure from higher rates or slower venture-debt activity.
Analyst Price Targets and Consensus View
Six recent price targets underpin the $5.00 average. BTIG sits at $4.50, Keefe, Bruyette & Woods holds $4.50 after a prior cut from $5, UBS is also at $4.50, and Oppenheimer is at $5.00. Compass Point started coverage at $5.50 with a Buy, while Maxim Group carries the highest target at $6.00. The mean comes to exactly $5.00, with the range spanning $4.50 to $6.00.
That spread is wide for a stock under $5 and reflects differing views on credit quality and earnings power rather than broad agreement. Bulls see value relative to NAV and income potential, while more cautious voices highlight coverage concerns and portfolio risks. The overall rating remains a Hold, and no analyst forecasts a return to the 52-week high near $6.85. I also checked this using Tickeron’s AI Daily Buy/Sell Signals to gauge recent momentum signals.
Current Market Position and Path Toward the Target
HRZN recently traded around $4.07, near the bottom of its 52-week range between $3.80 and $6.85. Reaching $5.00 would mean a gain of roughly 23%, which qualifies as substantial. The next key catalyst is third-quarter results due November 5, 2026, where attention will focus on net investment income sufficient to cover the $0.06 monthly base distribution plus the added $0.03 special distribution.
The April 2026 merger with Monroe Capital expanded the balance sheet and venture-debt platform. The debt portfolio yielded about 14.9% in the second quarter of 2026, and the stock trades near 0.66 times its reported NAV of roughly $6.23, providing a discount to book value.
Factors That Could Support a Move Higher
- A secured loan portfolio generating yields in the mid-teens.
- Valuation below NAV, which could offer downside protection if credit performance holds.
- Monthly distributions yielding near 18%, partly backed by spillover income.
- The Monroe Capital combination, which broadened capital resources and deal flow.
- A stable or rising-rate setting that supports floating-rate loan income.
Risks That Could Limit Upside
- Second-quarter NII of about $0.11 per share fell short of the combined quarterly payout, prompting questions on sustainability.
- Write-downs on a single investment have weighed on NAV in recent periods.
- Venture-backed borrowers remain exposed to shifts in funding or a slower technology cycle.
- Rate changes could narrow margins or slow portfolio expansion.
- The broad analyst range and multiple Hold ratings point to limited conviction in a quick re-rating.
Technical Levels and Market Structure
The stock has traded well below its 52-week high of $6.85, finding support in the $3.80–$4.00 area. The $5.00 mark serves as both a psychological and analytical resistance level just above the cluster of $4.50 targets. A sustained break above that zone would face the next ceiling near $6.00. Until the price reclaims higher ground within its recent range, the longer-term structure remains sideways to lower. From what I see, the technical picture reinforces the need for fundamental improvement before any meaningful re-rating.
Time Horizon and Key Items to Watch
Analyst targets generally reflect a 12-month horizon. The immediate focus is the November 5, 2026 earnings release, where investors should track NII per share, NAV changes, distribution coverage, and any new non-accruals or write-downs. Beyond that, Federal Reserve policy, venture-funding trends, portfolio yield movements, and adjustments to distributions will matter most. I’m watching this closely as earnings approach.
Monitoring Signals with AI Tools
One resource I turn to for ongoing monitoring of income names like this is Tickeron’s AI Daily Buy/Sell Signals. It applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on market conditions and technical shifts. This helps surface opportunities and track existing positions without constant manual review, which proves useful when following dividend-oriented holdings alongside other strategies.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
HRZN sees its Stochastic Oscillator ascending out of oversold territory
On October 30, 2026, the Stochastic Oscillator for HRZN moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 59 instances where the indicator left the oversold zone. In 29 of the 59 cases the stock moved higher in the following days. This puts the odds of a move higher at over 49%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HRZN's RSI Indicator exited the oversold zone, 21 of 48 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 44%.
Following a +5.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where HRZN advanced for three days, in 150 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 48%.
HRZN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HRZN as a result. In 43 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 58%.
HRZN moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HRZN crossed bearishly below the 50-day moving average on October 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 53%.
The 50-day moving average for HRZN moved below the 200-day moving average on October 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HRZN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
The Aroon Indicator for HRZN entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. HRZN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 75 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.653) is normal, around the industry mean (2.410). P/E Ratio (11.000) is within average values for comparable stocks, (-3.016). Projected Growth (PEG Ratio) (1.907) is also within normal values, averaging (1.319). Dividend Yield (0.088) settles around the average of (0.272) among similar stocks. P/S Ratio (11.062) is also within normal values, averaging (15.694).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HRZN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a closed-end investment trust
Industry InvestmentManagers
Advertisement